Sort   by:  
 Page size 
Mono-methylation of histone H3 on lysine 4 (H3K4me1) and acetylation of histone H3 on lysine 27 (H3K27ac) are histone modifications that are highly enriched over the body of actively transcribed genes and enhancers. Although in yeast all H3K4 methylation patterns including H3K4me1 are implemented by...
ORGANISM(S): Mus musculus 
FOXA1 is a pioneer factor that is important in hormone dependent cancer cells to stabilise nuclear receptors, such as estrogen receptor (ER) to chromatin. FOXA1 binds to enhancers regions that are enriched in H3K4mono- and dimethylation (H3K4me1, H3K4me2) histone marks and evidence suggests that the...
ORGANISM(S): Homo sapiens (Human) 
2016-12-12 | PXD005253 | Pride
Histone H3 lysine 4 (H3K4) can be mono-, di-, and trimethylated by members of the COMPASS (COMplex of Proteins ASsociated with Set1) family from yeast to human and these modifications can be found at distinct regions of the genome. Monomethylation of histone H3K4 (H3K4me1) is relatively more enriche...
ORGANISM(S): Homo sapiens 
Effect of Mll3 deletion in MCF7 cells
We investigated the in vivo role of MLL3-dependent methylation of histone 3 lysine 4 at zeitgeber time 18, by performing H3K4me1 and H3K4me3 ChIP-seq in mouse liver, from MLL3 Delta mice and littermate wild-type controls.
ORGANISM(S): Mus musculus 
Recurring deletions of chromosome 7 and 7q [-7/del(7q)] occur in myelodysplastic syndromes and acute myeloid leukemia (AML) and are associated with poor prognosis. However, the identity of specific tumor suppressors on 7q remains elusive. Using RNAi and CRISPR/Cas9 approaches, we show that a ~50% r...
ORGANISM(S): Mus musculus 
MLL3 is a de novo Cause of Endocrine Therapy Resistance
Identification of MLL3 and Calcineurin genomic targets in hypertrophic hearts
MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity [ChIP-seq]
MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity [RNA-seq]
Sort   by:  
 Page size